With outstanding customization options, an epic sensor, wireless connectivity, and stunningly lightweight, the Pathfinder is exemplary. Really, it's only mildly let down by its price and the fact that ...

INDIANAPOLIS -- The Colts were going about their usual Sunday morning routines ahead of their 1 p.m. ET kickoff against the Arizona Cardinals when a seemingly normal day became anything but routine.

There’s something weird in the water in Indianapolis lately. The Colts had a couple of unusual injuries during pregame warmups before Sunday’s win over the Cardinals. Cornerback Charvarius Ward ...

Bristol Myers Squibb (NYSE:BMY) has agreed to acquire privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash. Orbital Therapeutics is advancing a new generation of RNA ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

BMS will acquire Orbital Therapeutics and its CAR T-cell therapy OTX-201 to diversify its cell therapy portfolio. The acquisition involves a $1.5 billion cash transaction, subject to customary closing ...

Francesco Cacciatore is a self-proclaimed skeptic. Yet after spending two decades in the European aerospace industry and hitting, as he put it, a “crisis,” he made an undeniably optimistic bet: He ...

The U.S. Space Force is funding the development of a new "Orbital Carrier" spacecraft that can deploy multiple satellites when needed. The Orbital Carrier is being designed by Seattle-based company ...

In February, the Book Review Book Club will read and discuss “Orbital,” a Booker Prize-winning novel following six people living and working on a space station above Earth. By MJ Franklin MJ Franklin ...